These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10649731)

  • 61. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
    Johansen KL
    Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
    [No Abstract]   [Full Text] [Related]  

  • 62. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
    Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
    Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of androgens in chronic renal failure patients on maintenance hemodialysis.
    Alexander MR
    Am J Hosp Pharm; 1976 Mar; 33(3):242-8. PubMed ID: 769543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Androgens, erythropoietin, iron stores, and lipoprotein (a) in hemodialysis patients.
    Fourtounas C; Tzanatos H; Fourtounas C; Kopelias I; Agroyannis B
    Am J Kidney Dis; 1997 Dec; 30(6):935-6. PubMed ID: 9398146
    [No Abstract]   [Full Text] [Related]  

  • 65. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 66. [Anemia and hormone therapy for patients on intermittent chronic hemodialysis].
    Matsuoka H; Tamura T
    Horumon To Rinsho; 1974 Aug; 22(8):951-4. PubMed ID: 4476258
    [No Abstract]   [Full Text] [Related]  

  • 67. Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics.
    Solomon LR; Hendler ED
    Acta Haematol; 1988; 79(1):12-9. PubMed ID: 3124456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Catamnestic results following therapy of heart patients with anabolic steroids].
    Fiegel G; Bargheer R
    Med Klin; 1966 Nov; 61(47):1870-2. PubMed ID: 5989967
    [No Abstract]   [Full Text] [Related]  

  • 69. Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) vs testosterone enanthate (TE) (Androgens and dialysis patient).
    Mirahmadi MK; Vaziri ND; Gorman JT
    Trans Am Soc Artif Intern Organs; 1979; 25():449-54. PubMed ID: 524621
    [No Abstract]   [Full Text] [Related]  

  • 70. Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration.
    Johnson MW; Anch AM; Remmers JE
    Am Rev Respir Dis; 1984 Jun; 129(6):1023-5. PubMed ID: 6732043
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective controlled study of androgen effects on red cell oxygen transport and work capacity in chronic hemodialysis patients.
    Hendler ED; Solomon LR
    Acta Haematol; 1990; 83(1):1-8. PubMed ID: 2105563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Erythropoietic effect of androgen on anemia associated with Klinefelter's syndrome].
    Mitsutani S; Kamio M; Kohriyama T; Ishibashi T; Saito T
    Rinsho Ketsueki; 1988 Jun; 29(6):896-900. PubMed ID: 2458494
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of androgens and anabolic steroids in the treatment of cancer.
    Brodsky I
    Semin Drug Treat; 1973; 3(1):15-25. PubMed ID: 4740371
    [No Abstract]   [Full Text] [Related]  

  • 74. The effective use of nandrolone decanoate in the management of the anemia of uremia: a prospective study.
    Armitage JO; Leighton M; Ware F
    Nebr Med J; 1976 Jun; 61(6):202-6. PubMed ID: 1272455
    [No Abstract]   [Full Text] [Related]  

  • 75. [The treatment of refractory anemia with androgens and anabolic steroids].
    Wijnja L
    Ned Tijdschr Geneeskd; 1966 Dec; 110(50):2219-22. PubMed ID: 5341966
    [No Abstract]   [Full Text] [Related]  

  • 76. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
    Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
    G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
    [No Abstract]   [Full Text] [Related]  

  • 77. [Treatment of aplastic anemias with androgens].
    Vahancík A
    Vnitr Lek; 1974 Sep; 20(8):821-7. PubMed ID: 4850027
    [No Abstract]   [Full Text] [Related]  

  • 78. [Treatment of hypoplastic anemias with protein anabolic steroids].
    Vlassembrouck M; Lederer J
    Rev Fr Endocrinol Clin; 1966; 7(5):389-96. PubMed ID: 5971593
    [No Abstract]   [Full Text] [Related]  

  • 79. Androgen therapy in hemodialysis patients.
    De Palma JR; Abukurah A
    Proc Clin Dial Transplant Forum; 1972; 2():123-4. PubMed ID: 4681298
    [No Abstract]   [Full Text] [Related]  

  • 80. Antifracture efficacy of long-term estrogens for osteoporosis.
    Gordan GS; Picchi J; Roof BS
    Trans Assoc Am Physicians; 1973; 86():326-32. PubMed ID: 4363387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.